91猫先生

学歷

经歷

2015/08~  长庚大学專任教授

2012词2022&苍产蝉辫;高雄长庚医院人体生物资料库主任

2007~2015 长庚大学專任副教授

2003~2007 长庚大学助理教授

2002词2010&苍产蝉辫;高雄长庚医院解剖病理科主任

1998词1999&苍产蝉辫;长庚护专讲师

1998词2002&苍产蝉辫;辅英技术学院讲师

1997词1998&苍产蝉辫;美国约翰霍普金斯大学研究员

1994~     高雄長庚醫院病理科主治醫師

1993词1994&苍产蝉辫;高雄长庚医院病理科住院总医师

1990词1993&苍产蝉辫;高雄长庚医院病理科住院医师

学会与认证

台湾病理学会

台湾个人化医学研究学会

台湾头颈部肿瘤医学会

United states and Canadian Academy of Pathology

Asia-Australasia Pulmonary Pathology Society (President-elect)

研究计画(近叁年)

1. DLK1訊息調節惡性卵巢癌細胞之癌幹細胞化，化療抗藥性與免疫監控之研究，國科會計畫(2022/08/01~2023/07/31)

2. 在Sorafenib抗药性肝癌中探讨cyclooxygenase-2 / prostaglandin E2讯息传递於癌症干细胞与免疫监控上扮演的角色，长庚医学研究计画(2022/11/01~2025/10/31)

3. 研究Delta?like 1 Homolog (DLK1)在肝癌T细胞免疫监控与肿瘤进程的角色，国科会计画(2023/08/01~2026/07/31)

近年论文发表

1.     Huang CC*, Kuo HM*, Wu PC, Cheng SH, Chang TT, Chang YC, Kung ML, Wu DC, Chuang JH, Tai MH. Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch 1/Akt/eNOS signaling in endothelial cells. Angiogenesis 2018 May;21(2):299-312.  (SCI) (*Co-first author)

2.     Huang CC*, Cheng SH, Wu CH, Li WY, Wang JS, Kung ML, Chu TH, Huang ST, Feng CT, Huang SC, Tai MH*. Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling. Oncogene 2019 April;38:3201-3215.  (SCI) (First author and *co-corresponding author)

3.     Chen CM, Chu TH, Chou CC, Chien CY, Wang JS, Huang CC*. Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis. Oral Oncol 2021 Sep;120:105402. (SCI) (Corresponding author)

4.     Chu TH, Chou YW, Lin SL, Lin SF, Chen HH, Hu WH, Chen YY, Chang-Chien GP, Chang JH, Tsai MC, Huang CC*. A pilot study examining the relationship between environmental contaminants and colorectal cancer at a single medical institute in Taiwan. Taiwan J Public Health 2021 Oct;40(4):382-393. (Corresponding author)

5.     Wang CC, Huang KT, Chang HC, Tseng CC, Lai CH, Lan J, Liu TT, Huang CC*, Lin MC*. Comprehensive analysis of PD-L1 in non-small cell lung cancer with emphasis on survival benefit, impact of driver mutation and histological types, and archival tissue. Thorac Cancer 2022 Jan;13:38-47. (SCI) (Co-corresponding author)

6.     Kuo TY, Huang CC, Shieh SJ, Wang YB, Lin MJ, Wu MC, Huang LLH. Skin wound healing assessment via an optimized wound array model in miniature pigs. Sci Rep 2022 Jan;12(1):445. (SCI)

7.     Lee MG, Lee YK, Huang SC, Chang CL, Ko CY, Lee WC, Chen TY, Tzou SJ, Huang CY, Tai MH, Lin YW, Kung ML, Tsai MC, Chen YL, Chang YC, Wen ZH, Huang CC*, Chu TH*. DLK2 acts as a potential prognostic biomarker for clear cell renal cell carcinoma based on bioinformatics analysis. Genes 2022 Apr;13(4),629. (SCI) (Co-corresponding author)

8.     Huang GK, Huang CC, Kang CH, Cheng YT, Tsai PC, Kao YH, Chung YH. Genetic interference of FGFR3 impedes invasion of upper tract urothelial carcinoma cells by alleviating RAS/MAPK signal activity. Int J Mol Sci 2023 Jan;24(2):1776. (SCI)

9.     Wu JC, Huang CC, Wang PW, Chen TY, Hsu WM, Chuang JH, Chuang HC. ONC201 suppresses neuroblastoma growth by interrupting mitochondrial function and reactivating nuclear ATRX expression while decreasing MYCN. Int J Mol Sci 2023 Jan;24(2):1649. (SCI)

10.  Huang SC*, Huang CC*, Ko CY, Huang CY, Liu CH, Lee YK, Chen TY, Hsueh CW, Tzou SJ, Tai MH, Hu TH, Tsai MC, Lee WC, Ho YC, Wu CC, Chang YC, Chang JJ, Liu KH, Li CC, Wen ZH, Chang CL, Chu TH. Slow skeletal muscle troponin T acts as a potential prognostic biomarker and therapeutic target for hepatocellular carcinoma. Gene 2023 May;865:147331. (SCI) (*Co-first author)